BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids, derived from a protein naturally found in human gastric juice. It is widely studied in preclinical research for its role in tissue repair, angiogenesis, and cytoprotective signalling.

How do I reconstitute BPC-157?

Reconstitute with 1-2 ml of bacteriostatic water. Allow the vial to reach room temperature, inject solvent gently down the inside wall, and swirl gently. Never shake. Store reconstituted solution at 2-8°C and use within 4-6 weeks.

What purity is BioLab's BPC-157?

Every batch is independently tested via HPLC and mass spectrometry to confirm 99%+ purity and correct molecular identity. A batch-specific Certificate of Analysis is available with every order.

How should I store BPC-157?

Store lyophilised vials at -20°C, protected from light and moisture. Once reconstituted with bacteriostatic water, store at 2-8°C and use within 4-6 weeks. Avoid repeated freeze-thaw cycles.

Ipamorelin 2 mg

£20.00

Ipamorelin is a selective growth hormone secretagogue — a pentapeptide that stimulates GH release from the anterior pituitary via the ghrelin/GHS receptor without significantly affecting cortisol or prolactin levels. Available to buy in the UK from BioLab Peptides, this 2 mg lyophilised vial is HPLC-verified to 99%+ purity.

Purity: ≥99% (HPLC & mass spectrometry verified)
Quantity: 2 mg per vial
Form: Lyophilised (freeze-dried) powder
CAS: 170851-70-4
Amino Acids: 5 residues (pentapeptide)
Storage: -20°C (lyophilised) · 2–8°C (reconstituted)

Categories: All Peptides, Growth Hormone Secretagogues, Peptide Blends & Stacks

Description
Reviews (0)

Ipamorelin 2 mg — Selective Growth Hormone Secretagogue

Ipamorelin is a synthetic pentapeptide growth hormone secretagogue that acts on the growth hormone secretagogue receptor (GHS-R/ghrelin receptor) to stimulate pulsatile GH release from the anterior pituitary. What distinguishes Ipamorelin from other GHRP-class peptides is its high selectivity — preclinical studies indicate it stimulates GH release without the significant cortisol and prolactin elevations associated with GHRP-2 and GHRP-6.

This selectivity makes Ipamorelin particularly valuable in research settings where investigators need to study GH-mediated effects in isolation, without the confounding influence of cortisol-driven stress responses or prolactin-mediated pathways.

Product Specifications

Product Name	Ipamorelin 2 mg
Molecular Formula	C₃₈H₄₉N₉O₅
Molecular Weight	711.85 g/mol
CAS Number	170851-70-4
Amino Acids	5 residues (pentapeptide)
Target Receptor	GHS-R (ghrelin receptor)
Purity	≥99% (HPLC & MS verified)
Form	White lyophilised powder
Solubility	Water-soluble (bacteriostatic water)
Storage	-20°C (lyophilised) · 2–8°C (reconstituted, use within 4 weeks)

Research Background

Selective GH release — Ipamorelin activates the GHS-R to trigger GH secretion in a dose-dependent manner while producing minimal effects on ACTH (and therefore cortisol) and prolactin secretion. This selectivity distinguishes it from GHRP-2 and GHRP-6, which show broader hormonal effects.

Synergistic combination research — Ipamorelin is commonly studied alongside GHRH analogues such as CJC-1295 (MOD GRF 1-29). The rationale: GHRH analogues prime the pituitary for GH release while GHS-R agonists like Ipamorelin amplify the secretory pulse. Together, they are thought to produce synergistic GH output greater than either compound alone.

Metabolic and body composition research — GH-axis modulation through selective secretagogues like Ipamorelin allows researchers to study downstream effects on IGF-1 production, lipid metabolism, and body composition parameters without the metabolic side effects of direct GH administration.